The highly successful zombie franchise starring Will Smith is currently struggling to move past the development stage for its long-awaited sequel. Despite the original film's $585 million global success,a combination of budgetary issues and corporate shifts has stalled the project.
From Vincent Price to a $585 million global hit
The franchise's lineage traces back to Richard Matheson's original novel and a 1964 adaptation starring horror legend Vincent Price.. The 2013 remake, which blended classic plague-era horror with modern zombie tropes, became a massive commercial success. As the report notes, this version served as the franchise's true breakout, setting the stage for a massive global audience.
This legacy of genre-blending storytelling has kept fan interest high even during periods of inactivity. The original 2013 film's ability to capture the zeitgeist of the zombie craze has made the prospect of a follow-up a significant, albeit complicated, asset for the studio.
The $100 million Houston collapse and the Bay-Schwarzenegger era
A previous production attempt in Houston failed after costs reached a staggering $100 million. This era of development was marked by a high-profile team that included director Michael Bay and producer Arnold Schwarzenegger, though that specific arrangement eventually dissolved. According to the report, the project has since moved toward a new iteration directed by Francis Lawrence.
The hisotry of this sequel is a cycle of high-profile cancellations and subsequent resurrections. While Will Smith has taken on a more central role as both star and producer in recent attempts, the project has repeatedly hit logistical and financial walls that have prevented it from reaching a filming schedule.
Akiva Goldsman’s plan to kill off Dr. Robert Neville
Screenwriter Akiva Goldsman is currently revising a script that features Michael B. Jordan as a new protagonist alongside Will Smith. This new direction includes a major narrative gamble: the death of the original lead character, Dr. Robert Neville. This decision follows a history of narrative experimentation, such as the compassionate alternate ending revealed on the original film's home-video release, where Neville survives after discovering the creatures' true motives.
Goldsman has publicly admitted to running up against a series of obstacles, yet he remains determined to see the project through to complteion. the tension between maintaining the franchise's established tone and introducing radical new character deaths remains a central creative hurdle for the writing team.
Will the Warner Bros. and Paramount merger stall production?
The transition of Warner Bros. through a merger with Paramount has introduced a new layer of corporate caution regarding high-budget sequels.. Executives are reportedly wary of green-lighting expensive franchise films that may not provide immediate box-office returns. this leaves several critical questions unanswered: will the new studio leadership prioritize this horror saga over other major titles, can the creative disputes over the script be fully resolved, and how much will the industry's hesitation following Will Smith's recent controversies continue to impact negotiations?
Comments 0